Among the top stories in hematology/oncology last week were the FDA approving Nubeqa for the treatment of nonmetastatic castration-resistant prostate cancer and a study that found certain medications were linked to increased risk for breast cancer.
Would you like to receive email reminders to complete your saved activities from Healio CME?
Activity saved! You'll receive reminders to complete your saved activities from Healio CME.
